Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Disc Medicine, Inc. before investing.

In this article, we go over a few key elements for understanding Disc Medicine, Inc.’s stock price such as:

• Disc Medicine, Inc.’s current stock price and volume
• Why Disc Medicine, Inc.’s stock price changed recently
• Upgrades and downgrades for IRON from analysts
• IRON’s stock price momentum as measured by its relative strength

About Disc Medicine, Inc. (IRON)

Before we jump into Disc Medicine, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.

Want to learn more about Disc Medicine, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Disc Medicine, Inc..

Disc Medicine, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Disc Medicine, Inc.’s stock price was $77.000.

Disc Medicine, Inc. is down 2.79% from its previous closing price of $79.210.

During the last market session, Disc Medicine, Inc.’s stock traded between $75.010 and $79.310. Currently, there are approximately 38.69 million shares outstanding for Disc Medicine, Inc..

Disc Medicine, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Disc Medicine, Inc. Stock Price History

Disc Medicine, Inc.’s (IRON) price is currently up 5.28% so far this month.

During the month of July, Disc Medicine, Inc.’s stock price has reached a high of $82.500 and a low of $71.620.

Over the last year, Disc Medicine, Inc. has hit prices as high as $99.500 and as low as $40.000. Year to date, Disc Medicine, Inc.’s stock is down 3.03%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Disc Medicine, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Disc Medicine, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Disc Medicine, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Disc Medicine, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Disc Medicine, Inc. (IRON) by visiting AAII Stock Evaluator.

Relative Price Strength of Disc Medicine, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Disc Medicine, Inc. has a weighted four-quarter relative price strength of 5.26%, which translates to a Momentum Score of 71 and is considered to be Strong.

Want to learn more about how Disc Medicine, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Disc Medicine, Inc. Stock Price: Bottom Line

As of July 31, 2026, Disc Medicine, Inc.’s stock price is $77.000, which is down 2.79% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Disc Medicine, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.